VitaSpring Biomedical Co. Ltd. reported earnings results for the third quarter and nine months ended October 31, 2022. For the third quarter, the company reported net loss was USD 0.138004 million compared to USD 0.137453 million a year ago.
For the nine months, sales was USD 1.49 million compared to USD 2.12 million a year ago. Net loss was USD 0.00576 million compared to net income of USD 0.322629 million a year ago.